Intervention Review

You have free access to this content

Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation

  1. Fauzia A Khan*,
  2. Hameed Ullah

Editorial Group: Cochrane Anaesthesia, Critical and Emergency Care Group

Published Online: 3 JUL 2013

Assessed as up-to-date: 1 JUN 2011

DOI: 10.1002/14651858.CD004087.pub2


How to Cite

Khan FA, Ullah H. Pharmacological agents for preventing morbidity associated with the haemodynamic response to tracheal intubation. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD004087. DOI: 10.1002/14651858.CD004087.pub2.

Author Information

  1. Aga Khan University Hospital, Department of Anaesthesiology, Karachi, Sindh, Pakistan

*Fauzia A Khan, Department of Anaesthesiology, Aga Khan University Hospital, Stadium Road, PO Box 3500, Karachi, Sindh, 74800, Pakistan. fauzia.khan@aku.edu.

Publication History

  1. Publication Status: New
  2. Published Online: 3 JUL 2013

SEARCH

[Figure 1]
Figure 1. Flow diagram.
[Figure 2]
Figure 2. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Figure 3]
Figure 3. Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Arrhythmias, Outcome 1 Arrhythmias - by drug type.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Arrhythmias, Outcome 2 Arrhythmias - sympathetic blockers.
[Analysis 1.3]
Analysis 1.3. Comparison 1 Arrhythmias, Outcome 3 Arrhythmias - high risk vs low risk patients.
[Analysis 2.1]
Analysis 2.1. Comparison 2 ECG evidence of myocardial ischaemia, Outcome 1 Myocardial ischaemia - by drug type.
[Analysis 2.2]
Analysis 2.2. Comparison 2 ECG evidence of myocardial ischaemia, Outcome 2 Myocardial ischaemia - high risk vs low risk patients.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Adverse effects, Outcome 1 Local anaesthetics.
[Analysis 3.2]
Analysis 3.2. Comparison 3 Adverse effects, Outcome 2 Beta blockers.
[Analysis 3.3]
Analysis 3.3. Comparison 3 Adverse effects, Outcome 3 Combined alpha and beta blockers.
[Analysis 3.4]
Analysis 3.4. Comparison 3 Adverse effects, Outcome 4 Narcotics.
[Analysis 3.5]
Analysis 3.5. Comparison 3 Adverse effects, Outcome 5 Miscellaneous.